Spinocerebellar ataxia type 7: Description of a Mexican family;Ataxia espinocerebelosa de tipo 7: Descripción de una familia Mexicana

Revista de Neurologia

Volumn 38, Issue 8, 2004, Pages 736-740

  Rolón Lacarriere, Oscar ^a,c   Rasmussen Almaraz, A ^b   Hernandez Cruz H ^a   Carranza Del Rio J ^a   Gonzalez Cruz M ^a   Gutierrez Moctezuma J ^a  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

^b Instituto de Neurología y Neurocirugía de México   (Mexico)

^c Delegacion Benito Juarez ^*  (Mexico)

Author keywords

Ataxia; Autosomal dominant cerebellar ataxia; Genetic; Hereditary ataxias; Mexico; SCA 7; Spinocerebellar ataxia 7

Indexed keywords

ADULT; ANTICIPATION; ANTICIPATION PHENOMENON; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; BRAIN STEM; BRAIN STEM ATROPHY; CAG TRINUCLEOTIDE REPEAT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CHILD; CHROMOSOME 3P; CLINICAL ARTICLE; CLINICAL EXAMINATION; DEGENERATIVE DISEASE; FAMILY STUDY; FEMALE; GAIT DISORDER; GENE; GENE MAPPING; GENETIC LINKAGE; GLOBAL CEREBELLAR SYNDROME; HEMISPHERIC ATROPHY; HUMAN; MALE; MEXICO; MOLECULAR GENETICS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; OPHTHALMOLOGY; OPHTHALMOPLEGIA; PEDIGREE; PHENOMENOLOGY; PYRAMIDAL SIGN; RETINA DEGENERATION; RETINA DYSTROPHY; RETINA MACULA PIGMENT DYSTROPHY; SCA 7 GENE; SPASTICITY; SPINOCEREBELLAR DEGENERATION; SPINOCEREBELLAR DEGENERATION TYPE 7; SYNDROME; TRINUCLEOTIDE REPEAT; VISUAL IMPAIRMENT; AGED; CASE REPORT; DISEASE COURSE; DOMINANT GENE; GENETICS; MIDDLE AGED; PHENOTYPE; PRESCHOOL CHILD;

ATAXIN 7; ATAXIN-7; NERVE PROTEIN;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GENES, DOMINANT; HUMANS; MALE; MEXICO; MIDDLE AGED; NERVE TISSUE PROTEINS; PEDIGREE; PHENOTYPE; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 2942731725     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3808.2003624     Document Type: Article

References (21)

1. Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA-7 define abroad clinical spectrum and the infantile phenotype. Neurology 1998; 51: 1081-5.
2. Tan EK, Ashizawa T. Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol 2001; 58: 191-5.
3. Brunham LR, Chan EYW, Orban PC, Levings MK. Discoveries in sphingolipid metabolism, spinocerebellar ataxia and autoimmune disease. Clin Genet 2003; 64: 1-6.
4. Chan EY. A new mechanism for spinocerebellar ataxia involving mutations in proteinkinase C. Clin Genet 2003; 64: 3-4.
5. Matsumara R, Futamura N, Andon N, Veno S. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand 2003; 107: 38-41.
6. Sobrido MJ, Geschwind DH. Molecular genetics and inherited ataxias: redefining phenotypes and patogenesis. Neuroscientist 2000; 6: 465-74.
7. Devos D, Schraen M, Vuillaume, Dujardin K, Nazé P, Willoteaux C, et al. Clinical features and genetic analysis of a new form of spinocerebellar ataxia. Neurology 2001; 56: 234-8.
8. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7 (SCA 7) shows a cone-rod dystrophy phenotype. Exp Eye Res 2002; 74: 737-45.
9. Grattan-Smith PJ, Healeyy S, Grigg JR, Christodoulou J. Spinocerebellar ataxia type 7: A distinctive form of autosomal dominant cerebellar ataxia with retinopathy and marked genetic anticipation. J Paediatr Child Health 2001; 37: 81-4.
10. Modi G, Modi M, Martinus F, Rodda J, Saffer D. The clinical and genetic characteristics of spinocerebellar ataxia type 7 (SCA7) in three black South African families. Acta Neurol Scand 2000; 101: 177-82.
11. Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, et al. Distribution of ataxin 7 in normal human brain and retina. Brain 2000; 123: 2519-30.
12. Ruggieri V, Arberas C. Ataxias hereditarias. Rev Neurol 2000; 31: 288-96.
13. Andrew K, Oh K, Jacobson JC, et al. Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7. Ann Neurol 2001; 49: 801-4.
14. Sobrido MJ. Molecular Genetics and inherited ataxias: refining phenotypes and pathogenesis. Neuroscientist 2000; 6: 465-74.
15. Castañeda-Reyna MA, Ávalos C, Jerí R. Investigación clínica y genética de una familia peruana afectada por ataxia espinocerebelosa tipo 7. Rev Neurol 2000; 31: 923-8.
16. Jobsis GJ, Weber JW, Barth PG, Keizers H, Baas F, Schooneveld MJ, et al. Autosomal dominant cerebellar ataxia with retinal degeneration (ADCA II): clinical and neurolopathological findings in two pedigrees and genetic linkage to 3p12-21.1. J Neurol Neurosurg Psychiatry 1997; 62: 367-71.
17. Melberg A, Dahl N, Hetta J, Valind S, Nennesmo I, Lundberg PO, et al. Neuroimaging study in autosomal dominant cerebellar ataxia, deafness and narcolepsy. Neurology 1999; 53: 2190-2.
18. Mayo-Cabrero D, Yusta-Izquiedo A, Vázquez-Miralles JM, García-Ruiz Espiga PJ, Robledo-Batanero M, Benítez J. Ataxia espinocerebelosa tipo VII (AEC 7): comunicación de una familia afectada española. Rev Neurol 1999; 28: 964-6.
19. Velázquez-Pérez L, García R, Santos FN, Paneque HM, Medine HE, Hechavarría PR. Las ataxias hereditarias en Cuba. Aspectos históricos, epidemiológicos, clínicos, electrofisiológicos y de neurología cuantitativa. Rev Neurol 2001; 32: 71-6.
20. Masafumi O. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration. J Neurol Sci 2003; 210: 53-6.
21. Horiuchi M. Therapeutic efficacy of transcranial magnetic stimulation for amyotrophyc lateral sclerosis and spinocerebellar degeneration. Int Cong Ser 2002; 1235: 525-32.